NSC |
Compound |
Enrichment |
Correlation |
NSC 710895 |
3-[(1H-Indol-3-ylethyl)amino]-2-(3-isopropoxyphenyl)-2H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxide |
0.0435808621943462 |
0.4568495 |
NSC 715778 |
Null |
0.0435808621943462 |
0.33747722 |
NSC 716032 |
Null |
0.0435808621943462 |
0.34058152 |
NSC 722854 |
1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline |
0.0435808621943462 |
0.43581841 |
NSC 723548 |
Null |
0.0435808621943462 |
0.42746511 |
NSC 723732 |
8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one |
0.0435808621943462 |
0.455673 |
NSC 728035 |
1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di |
0.0435808621943462 |
0.25129789 |
NSC 735030 |
Null |
0.0435808621943462 |
0.4347776 |
NSC 743528 |
Null |
0.0435808621943462 |
0.30720491 |
NSC 751152 |
3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone |
0.0435808621943462 |
0.59845578 |